VePesid

Active Ingredient(s): Etoposide, VP-16
FDA Approved: * November 10, 1983
Pharm Company: * BRISTOL MYERS SQUIBB
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



VePesid Overview

Etoposide, sold under the brand name Etopophos among others, is a chemotherapy medication used for the treatments of a number of types of cancer.[1] This includes testicular cancer, lung cancer, lymphoma, leukemia, neuroblastoma, and ovarian cancer.[1] It is used by mouth or injection into a vein.[1] Side effects are very common.[1] They can include low blood cell counts, vomiting, loss of appetite, diarrhea, hair loss, and fever...

Read more VePesid Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Etoposide

Recent VePesid Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Etoposide, VP-16
  • Capsule: 100mg, 50mg
  • Injection: 100mg, 20mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Etoposide, VP-16 or a similar ingredient: (3 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 13 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA